05:33 PM EDT, 08/19/2025 (MT Newswires) -- Tolga Tanguler, Executive Vice President, Chief Commercial Officer, on August 15, 2025, sold 1,396 shares in Alnylam Pharmaceuticals ( ALNY ) for $632,759. Following the Form 4 filing with the SEC, Tanguler has control over a total of 29,466 common shares of the company, with 29,466 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000091/xslF345X05/edgardoc.xml